Tuesday, August 21, 2018

Tops in Pharma 4.0.

Werum IT Solutions has been recognized as one of the “Top 10 Pharma & Life Science Solution Providers 2018” by APAC CIO Outlook*.

With the certificate of honour, a distinguished panel of CIOs, CEOs and VCs including the APAC CIO Outlook editorial board selected companies that are successfully tackling the challenges of the pharma and biotech industries by adopting technology advancements and paving the way to Pharma 4.0. Werum IT Solutions is the only MES supplier which has received this prestigious award this year. Read their full article on-line here, "Vangards of Pharma 4.0."

We are proud to have been recognized as the leading provider of Manufacturing Execution Systems, MES, for the pharma and life sciences industry in Asia for the last three consecutive years,” said David Margetts, Managing Director, Werum IT Solutions Ltd., Thailand.


David Margetts
“Our PAS-X MES has become the centerpiece for pharma manufactures to shape the future Pharma 4.0 world, including advancements in Enterprise Manufacturing Intelligence, Mobility, Software as a Service and Plug & Produce integration that will truly enable Industry 4.0 and IoT within pharma facilities.

“Our clients are well beyond just thinking about the buzzwords Augmented Reality, Voice Integrated Systems, Cloud, and Big Data as they have already implemented pilots and commercial applications on top of our PAS-X solution today! To be honored as one of the Top 10 Pharma & Life Science Solution Providers in APAC is a great motivation for our entire team to continue to serve our customers even better. We are grateful for our customers’ trust and would like to thank our partners around the region for their valuable contributions in our success.”

* APAC CIO Outlook is a monthly magazine published in Silicon Valley, USA, that aims to provide a platform for CxOs of solution providers and to share their expertise with the enterprise IT community of Asia-Pacific countries.


@Werum #PAuto @APACCIOoutlook

No comments:

Post a Comment